Artificial Intelligence for Regional Lung Ventilation Intelligence

Abstract

Artificial intelligence (AI) is revolutionizing the assessment and management of regional lung ventilation, offering unprecedented accuracy and clinical utility. By integrating advanced algorithms with high-resolution imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and electrical impedance tomography (EIT), AI-driven tools are enhancing the precision of ventilation mapping, optimizing patient outcomes, and informing evidence-based interventions. This review explores the scientific foundations, clinical relevance, and practical applications of AI in regional lung ventilation intelligence, emphasizing recent advances, emerging therapies, and evolving guideline recommendations for healthcare professionals.

Introduction

Regional lung ventilation assessment is pivotal in diagnosing, monitoring, and managing various pulmonary diseases, especially those characterized by heterogeneous lung involvement such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Traditional approaches to evaluating regional ventilation have been limited by subjective interpretation and technological constraints. The advent of artificial intelligence, leveraging machine learning, deep learning, and computer vision, has enabled objective, reproducible, and clinically meaningful analysis of regional lung function. This article provides a comprehensive review of AI applications in regional lung ventilation, focusing on the integration of advanced imaging, clinical decision support, and patient-centered outcomes.

Epidemiology / Disease Burden

Globally, respiratory diseases account for substantial morbidity and mortality, with COPD, ARDS, and asthma among the leading causes of hospital admissions and healthcare resource utilization. Regional ventilation defects are common in these conditions, contributing to hypoxemia, impaired gas exchange, and poor clinical outcomes. The World Health Organization (WHO) estimates that over 300 million people suffer from chronic respiratory diseases, underscoring the need for precise and individualized assessment tools. In critical care settings, mismanagement of ventilation can exacerbate lung injury, highlighting the clinical imperative for intelligent, evidence-based approaches to regional lung function assessment.

Pathophysiology

Regional ventilation heterogeneity arises from diverse pathophysiological mechanisms, including airway obstruction, alveolar collapse, consolidation, and vascular shunting. In diseases like ARDS, the loss of aerated lung units and formation of non-homogenous lung regions lead to "baby lung" phenomena, where a small portion of the lung receives the majority of the tidal volume, increasing the risk of volutrauma and barotrauma. AI-powered imaging analysis enables the quantification and visualization of these regional differences, facilitating targeted interventions and minimizing ventilator-induced lung injury.

Risk Factors

Numerous risk factors predispose patients to regional ventilation abnormalities, including advanced age, smoking, environmental exposures, pre-existing lung diseases, and genetic susceptibility. In mechanically ventilated patients, risk factors such as high tidal volumes, inappropriate positive end-expiratory pressure (PEEP), and supine positioning can further exacerbate regional disparities in ventilation. AI-based predictive analytics can stratify patient risk, inform ventilatory strategies, and identify those who may benefit from advanced monitoring and individualized care.

Clinical Features

Patients with regional ventilation defects often present with dyspnea, hypoxemia, hypercapnia, and radiographic evidence of patchy opacities or atelectasis. Clinical features may be subtle or masked, particularly in sedated or critically ill patients. AI-assisted imaging modalities can detect subclinical abnormalities, guide clinical assessment, and support early intervention, potentially altering the course of disease and improving prognosis.

Diagnosis

Diagnostic evaluation of regional lung ventilation traditionally relies on spirometry, arterial blood gases, and imaging studies. However, conventional imaging may fail to capture the dynamic and heterogeneous nature of lung ventilation. AI algorithms applied to CT, MRI, and EIT generate high-resolution, quantitative maps of lung aeration, perfusion, and ventilation-perfusion (V/Q) matching. These tools enhance diagnostic accuracy, support differential diagnosis, and monitor response to therapy over time. Integrating AI with point-of-care ultrasound and bedside EIT further broadens diagnostic capabilities in diverse clinical environments.

Treatment & Management

Personalized ventilation strategies, informed by AI-driven regional assessment, are transforming the management of patients with acute and chronic lung diseases. AI can recommend optimal ventilator settings, such as tidal volume, PEEP, and recruitment maneuvers, tailored to the patient's specific lung mechanics and regional ventilation patterns. This individualized approach reduces the risk of ventilator-induced lung injury, enhances oxygenation, and accelerates recovery. In chronic disease management, AI-guided insights support rehabilitation, non-invasive ventilation adjustments, and monitoring of disease progression.

Recent Advances / Emerging Therapies

Recent advances in AI for regional lung ventilation include deep learning models capable of automated lung segmentation, regional compliance assessment, and V/Q mapping from standard imaging datasets. Emerging therapies harness real-time AI feedback during mechanical ventilation, enabling closed-loop systems that dynamically adjust settings based on continuous monitoring of regional lung function. Integrating AI with telemedicine platforms allows remote monitoring and decision support, extending the benefits of advanced ventilation intelligence to resource-limited settings. Ongoing trials are evaluating the impact of these innovations on clinical outcomes, including ventilator-free days, mortality, and long-term pulmonary function.

Guideline Recommendations

International guidelines emphasize the importance of lung-protective ventilation strategies and individualized care in patients with heterogeneous lung injury. The integration of AI into clinical workflows is increasingly supported by expert consensus statements, which advocate for the use of advanced imaging and computer-assisted analysis to optimize patient management. As evidence accumulates, formal guideline updates are anticipated to reflect the growing role of AI in regional ventilation assessment and individualized therapy.

Conclusion

Artificial intelligence is reshaping the landscape of regional lung ventilation assessment and management, providing clinicians with precise, actionable insights that enhance patient outcomes. By bridging the gap between advanced imaging, data analytics, and bedside care, AI-powered tools hold the promise of truly personalized respiratory support. Continued research, multidisciplinary collaboration, and integration into clinical guidelines will be essential to realize the full potential of AI in respiratory medicine, ensuring safer, more effective, and equitable care for patients worldwide.